BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitko CL, Pidala J, Schoemans HM, Lawitschka A, Flowers ME, Cowen EW, Tkaczyk E, Farhadfar N, Jain S, Steven P, Luo ZK, Ogawa Y, Stern M, Yanik GA, Cuvelier GDE, Cheng GS, Holtan SG, Schultz KR, Martin PJ, Lee SJ, Pavletic SZ, Wolff D, Paczesny S, Blazar BR, Sarantopoulos S, Socie G, Greinix H, Cutler C. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report. Transplant Cell Ther 2021;27:545-57. [PMID: 33839317 DOI: 10.1016/j.jtct.2021.03.033] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao Y, Zhao W, Yang J, Wu S, Jin L, Huang F, Liang L. Vision-specific and cancer-specific quality of life in ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Graefes Arch Clin Exp Ophthalmol 2023;261:453-65. [PMID: 36029303 DOI: 10.1007/s00417-022-05812-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Booth G, Yu Y, Harlan RP, Jacoby CE, Tomic KM, Slater SE, Allen BE, Berklich EM, Knight RJ, Dela Cruz J, Fu R, Gandhi A, Cook RJ, Meyers G, Maziarz RT, Newell LF. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates. Cytotherapy 2023:S1465-3249(22)01024-6. [PMID: 36690537 DOI: 10.1016/j.jcyt.2022.11.004] [Reference Citation Analysis]
3 Hidalgo Calleja C, Sánchez González MD, Medina Luezas J, López Corral L. Enfermedad injerto contra receptor crónica: revisión sistemática de la afectación articular y fascial. Reumatología Clínica 2023. [DOI: 10.1016/j.reuma.2022.12.002] [Reference Citation Analysis]
4 Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain MH, Saliba R, Rondon G, Dickey BF, Bashoura L, Ost DE, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation. Transplant Cell Ther 2022:S2666-6367(22)01804-8. [PMID: 36503180 DOI: 10.1016/j.jtct.2022.12.001] [Reference Citation Analysis]
5 Flavin B. Chronic graft-vs-host disease: Current understanding of disease and treatment landscape. JMCP 2022;28:S2-S12. [DOI: 10.18553/jmcp.2022.28.12-b.s1] [Reference Citation Analysis]
6 Ogawa Y, Dana R, Kim S, Jain S, Rosenblatt MI, Perez VL, Clayton JA, Alves M, Rocha EM, Amparo F, Seo KY, Wang Y, Shen J, Oh JY, Vanathi M, Nair S, Na KS, Riemens A, Sippel K, Soifer M, Wang S, Trindade M, Kim MK, Yoon CH, Yagi R, Hiratsuka R, Ogawa M, Shimizu E, Sato Y, Pflugfelder S, Tsubota K. Multicenter prospective validation study for international chronic ocular graft-versus-host disease consensus diagnostic criteria. Ocul Surf 2022;26:200-8. [PMID: 36130695 DOI: 10.1016/j.jtos.2022.09.002] [Reference Citation Analysis]
7 Xu Y, Wang Y, Sun Z, Yang X, Zhuang X, Ren Y, Chen Y, Chen F, Ma X, Tang X, Zhang X. Corneal perforation associated with ocular graft-versus-host disease. Front Oncol 2022;12:962250. [DOI: 10.3389/fonc.2022.962250] [Reference Citation Analysis]
8 Kostareva I, Kirgizov K, Machneva E, Ustyuzhanina N, Nifantiev N, Skvortsova Y, Shubina I, Reshetnikova V, Valiev T, Varfolomeeva S, Kiselevskiy M. Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD. Pharmaceuticals (Basel) 2022;15:1100. [PMID: 36145321 DOI: 10.3390/ph15091100] [Reference Citation Analysis]
9 Kishida Y, Shingai N, Hara K, Yomota M, Kato C, Sakai S, Kambara Y, Atsuta Y, Konuma R, Wada A, Murakami D, Nakashima S, Uchibori Y, Onai D, Hamamura A, Nishijima A, Toya T, Shimizu H, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Impact of lung function impairment after allogeneic hematopoietic stem cell transplantation. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-18553-6] [Reference Citation Analysis]
10 Bidgoli A, Depriest BP, Saatloo MV, Jiang H, Fu D, Paczesny S. Current Definitions and Clinical Implications of Biomarkers in Graft-versus-Host Disease. Transplantation and Cellular Therapy 2022. [DOI: 10.1016/j.jtct.2022.07.008] [Reference Citation Analysis]
11 China Hematology Association, Chinese Medical Doctor Association;, Chinese Society of Hematology, Chinese Medical Association. [Chinese consensus on diagnosis and treatment of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation (2022)]. Zhonghua Xue Ye Xue Za Zhi 2022;43:441-7. [PMID: 35968585 DOI: 10.3760/cma.j.issn.0253-2727.2022.06.001] [Reference Citation Analysis]
12 Cuvelier GDE, Schoettler M, Buxbaum NP, Pinal-Fernandez I, Schmalzing M, Distler JHW, Penack O, Santomasso BD, Zeiser R, Angstwurm K, MacDonald KPA, Kimberly WT, Taylor N, Bilic E, Banas B, Buettner-Herold M, Sinha N, Greinix HT, Pidala J, Schultz KR, Williams KM, Inamoto Y, Cutler C, Md H, Lee SJ, Sarantopoulos S, Pavletic SZ, Wolff D. Towards a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplant Cell Ther 2022:S2666-6367(22)01334-3. [PMID: 35662591 DOI: 10.1016/j.jtct.2022.05.038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Colarusso BA, Bligdon SM, Ganjei AY, Kwok A, Brocks D, Luo ZK. Ocular Graft-versus-Host Disease Underdiagnosis: A Survey Study. OPTH 2022;Volume 16:1419-26. [DOI: 10.2147/opth.s359539] [Reference Citation Analysis]
14 Bujan Rivera J, Kühl R, Zech U, Hendricks A, Luft T, Dreger P, Friedmann-Bette B, Betz TM, Wiskemann J. Impact of Resistance Exercise and Nutritional Endorsement on physical performance in patients with GvHD (IRENE-G study) - design and rational of a randomized controlled trial. BMC Cancer 2022;22:440. [PMID: 35459108 DOI: 10.1186/s12885-022-09497-1] [Reference Citation Analysis]
15 McNeil A, Parks K, Liu X, Saknite I, Chen F, Reasat T, Cronin A, Wheless L, Dawant BM, Tkaczyk ER. Artificial intelligence recognition of cutaneous chronic graft-versus-host disease by a deep learning neural network. Br J Haematol 2022. [PMID: 35322873 DOI: 10.1111/bjh.18141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gehlsen U, Faust C, Blecha C, Dietrich-Ntoukas T, Eberwein P, Issleib S, Meyer-Ter-Vehn T, Braun R, Westekemper H, Steven P. Outcomes and complications of cataract surgery in patients with chronic ocular graft-versus-host-disease-a multicenter, retrospective analysis. Graefes Arch Clin Exp Ophthalmol 2022. [PMID: 35254513 DOI: 10.1007/s00417-022-05613-w] [Reference Citation Analysis]
17 Sobkowiak-sobierajska A, Lindemans C, Sykora T, Wachowiak J, Dalle J, Bonig H, Gennery A, Lawitschka A. Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan. Front Pediatr 2022;10:808103. [DOI: 10.3389/fped.2022.808103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Rayment JH, Sandoval RA, Roden JP, Schultz KR. Multiple breath washout testing to identify pulmonary chronic graft versus host disease in children after haematopoietic stem cell transplantation. Transplantation and Cellular Therapy 2022. [DOI: 10.1016/j.jtct.2022.02.002] [Reference Citation Analysis]
19 Levy RB, Mousa HM, Lightbourn CO, Shiuey EJ, Latoni D, Duffort S, Flynn R, Du J, Barreras H, Zaiken M, Paz K, Blazar BR, Perez VL. Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease. IJMS 2021;23:184. [DOI: 10.3390/ijms23010184] [Reference Citation Analysis]
20 Hamilton BK. Updates in chronic graft-versus-host disease. Hematology Am Soc Hematol Educ Program 2021;2021:648-54. [PMID: 34889364 DOI: 10.1182/hematology.2021000301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
21 Williams KM. Noninfectious complications of hematopoietic cell transplantation. Hematology Am Soc Hematol Educ Program 2021;2021:578-86. [PMID: 34889438 DOI: 10.1182/hematology.2021000293] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Inamoto Y, Zeiser R, Chan GC. Novel Treatment for Graft-versus-Host Disease. Blood Cell Ther 2021;4:101-9. [PMID: 36714067 DOI: 10.31547/bct-2021-022] [Reference Citation Analysis]
23 Shimizu S, Sato S, Taniguchi H, Shimizu E, He J, Hayashi S, Negishi K, Ogawa Y, Shimmura S. Observation of Chronic Graft-Versus-Host Disease Mouse Model Cornea with In Vivo Confocal Microscopy. Diagnostics (Basel) 2021;11:1515. [PMID: 34441450 DOI: 10.3390/diagnostics11081515] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wetzel L, Wittig S, Gruhn B. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children. J Cancer Res Clin Oncol 2021. [PMID: 34120222 DOI: 10.1007/s00432-021-03677-5] [Reference Citation Analysis]
25 Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, Jenq RR, Hanash AM, Jacobsohn D, Santomasso BD, Jain S, Ogawa Y, Steven P, Luo ZK, Dietrich-Ntoukas T, Saban D, Bilic E, Penack O, Griffith LM, Cowden M, Martin PJ, Greinix HT, Sarantopoulos S, Socie G, Blazar BR, Pidala J, Kitko CL, Couriel DR, Cutler C, Schultz KR, Pavletic SZ, Lee SJ, Paczesny S. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther 2021:S2666-6367(21)00949-0. [PMID: 34217703 DOI: 10.1016/j.jtct.2021.06.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
26 Gehlsen U, Stary D, Maass M, Riesner K, Musial G, Stern ME, Penack O, Steven P. Ocular Graft-versus-Host Disease in a Chemotherapy-Based Minor-Mismatch Mouse Model Features Corneal (Lymph-) Angiogenesis. Int J Mol Sci 2021;22:6191. [PMID: 34201218 DOI: 10.3390/ijms22126191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Shakshouk H, Tkaczyk ER, Cowen EW, El-Azhary RA, Hashmi SK, Kenderian SJ, Lehman JS. Methods to Assess Disease Activity and Severity in Cutaneous Chronic Graft-versus-Host Disease: A Critical Literature Review. Transplant Cell Ther 2021;27:738-46. [PMID: 34107339 DOI: 10.1016/j.jtct.2021.05.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]